{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:34:20Z","timestamp":1789914860055,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute","award":["P50 DA00254"],"award-info":[{"award-number":["P50 DA00254"]}]},{"name":"National Institute","award":["R01 DA015462"],"award-info":[{"award-number":["R01 DA015462"]}]},{"name":"National Institute","award":["R01 DA022243"],"award-info":[{"award-number":["R01 DA022243"]}]},{"name":"State of Michigan"},{"name":"Detroit Wayne Mental Health Authority"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.drugalcdep.2017.11.035","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:34:01Z","timestamp":1517560441000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Factors associated with sedative use and misuse among heroin users"],"prefix":"10.1016","volume":"185","author":[{"given":"Tabitha E.H.","family":"Moses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie H.","family":"Lundahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2015.08.005","article-title":"Prescription monitoring programs and emergency department visits involving benzodiazepine misuse: early evidence from 11 United States metropolitan areas","volume":"28","author":"Bachhuber","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1465-3362.2009.00101.x","article-title":"Benzodiazepine use among heroin users: baseline use, current use and clinical outcome","volume":"29","author":"Darke","year":"2009","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsat.2009.03.006","article-title":"Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients","volume":"37","author":"Fatseas","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0030","series-title":"Structured Clinical Interview for DSM-IV Axis Disorders \u2013 Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"1996"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugalcdep.2008.04.003","article-title":"Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome","volume":"97","author":"Ghitza","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.addbeh.2013.11.022","article-title":"Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses","volume":"39","author":"Goldner","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0970-9185.74581","article-title":"Clonidine in adults as a sedative agent in the intensive care unit","volume":"26","author":"Jamadarkhana","year":"2010","journal-title":"J. Anaesthesiol. Clin. Pharm."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0060","first-page":"4","article-title":"Comparative evaluation of oral midazolam, butorphanol and clonidine as premedicants in children undergoing elective surgery","author":"Jitendra","year":"2015","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2014.08.008","article-title":"Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms","volume":"144","author":"Kaye","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone and buprenorphine: interactions and clinical management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0090","series-title":"The CBHSQ Report: trends in heroin use in the United States: 2002\u20132013","author":"Lipari","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addbeh.2014.09.017","article-title":"Causal pathways between impulsiveness, cocaine use consequences, and depression","volume":"41","author":"Lister","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0100","first-page":"2121","article-title":"Addiction: part I. Benzodiazepines\u2013side effects, abuse risk and alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2015.03.046","article-title":"Chronology of illness in dual diagnosis heroin addicts: the role of mood disorders","volume":"179","author":"Maremmani","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2017.05.016","article-title":"High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City","volume":"46","author":"Mateu-Gelabert","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.addbeh.2014.01.009","article-title":"Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors","volume":"39","author":"McCabe","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.addbeh.2016.08.021","article-title":"Medical and nonmedical use of prescription sedatives and anxiolytics: adolescents\u2019 use and substance use disorder symptoms in adulthood","volume":"65","author":"McCabe","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0130","first-page":"S64","article-title":"Interactions between benzodiazepines and opioids","volume":"154","author":"Megarbane","year":"2003","journal-title":"Ann. Med. Interne"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0135","series-title":"Examining race differences in heroin use patterns among injection drug users: An analysis to guide preventative interventions","author":"Moses","year":"2018"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.addbeh.2017.07.027","article-title":"Developing a scale of domains of negative consequences of chronic heroin use","volume":"77","author":"Moses","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40261-016-0397-8","article-title":"Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995","volume":"36","author":"Murphy","year":"2016","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0150","series-title":"DrugFacts: Treatment Statistics","author":"National Institute on Drug Abuse","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2007.03.002","article-title":"Do trauma history and PTSD symptoms influence addiction relapse context?","volume":"90","author":"Norman","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2017.05.014","article-title":"Prescribing of benzodiazepines and opioids to individuals with substance use disorders","volume":"178","author":"O\u2019Brien","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3122\/jabfm.2014.03.130290","article-title":"Risk of adverse health outcomes with increasing duration and regularity of opioid therapy","volume":"27","author":"Paulozzi","year":"2014","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0175","first-page":"285","article-title":"Benzodiazepine usage during 19. 5 years in methadone maintenance treatment patients and its relation to long-term outcome","volume":"51","author":"Peles","year":"2014","journal-title":"Israel J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.genhosppsych.2015.06.004","article-title":"Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment","volume":"37","author":"Peters","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0185","series-title":"The TEDS Report: Substance Abuse Treatment Admissions for Abuse of Benzodiazepines","author":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0190","series-title":"The TEDS Report: Admissions Reporting Benzodiazepine and Narcotic Pain Reliever Abuse at Treatment Entry","author":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0195","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14\u20134863","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0200","series-title":"Prescription Drug Use and Misuse in the United States: Results from the 2015 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eurpsy.2013.08.006","article-title":"Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment","volume":"30","author":"Schellekens","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2016.08.638","article-title":"Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia","volume":"168","author":"Scott","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","author":"Stein","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0220","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.addbeh.2013.01.027","article-title":"Trauma histories, substance use coping, PTSD, and problem substance use among sexual assault victims","volume":"38","author":"Ullman","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13054-017-1610-8","article-title":"Clonidine for sedation in the critically ill: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.addbeh.2015.02.014","article-title":"Progression to regular heroin use: examination of patterns, predictors, and consequences","volume":"45","author":"Woodcock","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jadohealth.2012.01.011","article-title":"Nonmedical use of prescription medications among adolescents in the United States: a systematic review","volume":"51","author":"Young","year":"2012","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.drugalcdep.2017.11.035_bib0240","series-title":"The Manual of the Shipley Institute of Living ScaleTitle","author":"Zachary","year":"1991"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618300322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618300322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T20:19:54Z","timestamp":1660421994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618300322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":48,"alternative-id":["S0376871618300322"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.11.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with sedative use and misuse among heroin users","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}